Is JAMF undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6
Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of JAMF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: JAMF ($14.36) is trading below our estimate of fair value ($43.11)
Significantly Below Fair Value: JAMF is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for JAMF?
Key metric: As JAMF is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for JAMF. This is calculated by dividing JAMF's market cap by their current
revenue.
What is JAMF's PS Ratio?
PS Ratio
3x
Sales
US$615.07m
Market Cap
US$1.82b
JAMF key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: JAMF is good value based on its Price-To-Sales Ratio (3x) compared to the US Software industry average (5.1x).
Price to Sales Ratio vs Fair Ratio
What is JAMF's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
JAMF PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
3x
Fair PS Ratio
4.5x
Price-To-Sales vs Fair Ratio: JAMF is good value based on its Price-To-Sales Ratio (3x) compared to the estimated Fair Price-To-Sales Ratio (4.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst JAMF forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
US$14.36
US$22.89
+59.4%
13.7%
US$30.00
US$20.00
n/a
9
Nov ’25
US$16.80
US$22.89
+36.2%
13.7%
US$30.00
US$20.00
n/a
9
Oct ’25
US$16.95
US$23.00
+35.7%
13.3%
US$30.00
US$20.00
n/a
9
Sep ’25
US$18.50
US$23.63
+27.7%
13.4%
US$30.00
US$20.00
n/a
8
Aug ’25
US$17.67
US$24.25
+37.2%
11.2%
US$30.00
US$20.00
n/a
8
Jul ’25
US$16.86
US$24.25
+43.8%
11.2%
US$30.00
US$20.00
n/a
8
Jun ’25
US$15.92
US$24.25
+52.3%
11.2%
US$30.00
US$20.00
n/a
8
May ’25
US$19.60
US$22.83
+16.5%
13.2%
US$30.00
US$19.00
n/a
10
Apr ’25
US$18.20
US$22.83
+25.4%
13.2%
US$30.00
US$19.00
n/a
10
Mar ’25
US$17.60
US$22.44
+27.5%
15.4%
US$30.00
US$18.00
n/a
9
Feb ’25
US$18.73
US$23.00
+22.8%
13.4%
US$30.00
US$19.00
n/a
9
Jan ’25
US$18.06
US$23.00
+27.4%
13.4%
US$30.00
US$19.00
n/a
9
Dec ’24
US$17.38
US$23.00
+32.3%
13.4%
US$30.00
US$19.00
n/a
9
Nov ’24
US$15.36
US$25.56
+66.4%
18.5%
US$35.00
US$19.00
US$16.80
9
Oct ’24
US$17.66
US$25.56
+44.7%
18.5%
US$35.00
US$19.00
US$16.95
9
Sep ’24
US$17.36
US$25.56
+47.2%
18.5%
US$35.00
US$19.00
US$18.50
9
Aug ’24
US$21.31
US$26.33
+23.6%
16.6%
US$35.00
US$19.00
US$17.67
9
Jul ’24
US$19.52
US$25.89
+32.6%
18.1%
US$35.00
US$19.00
US$16.86
9
Jun ’24
US$18.04
US$25.89
+43.5%
18.1%
US$35.00
US$19.00
US$15.92
9
May ’24
US$18.54
US$27.22
+46.8%
14.0%
US$35.00
US$21.00
US$19.60
9
Apr ’24
US$19.42
US$27.22
+40.2%
14.0%
US$35.00
US$21.00
US$18.20
9
Mar ’24
US$20.60
US$27.22
+32.1%
14.0%
US$35.00
US$21.00
US$17.60
9
Feb ’24
US$21.66
US$28.22
+30.3%
15.6%
US$35.00
US$21.00
US$18.73
9
Jan ’24
US$21.30
US$29.44
+38.2%
14.3%
US$35.00
US$21.00
US$18.06
9
Dec ’23
US$21.51
US$29.44
+36.9%
14.3%
US$35.00
US$21.00
US$17.38
9
Nov ’23
US$23.47
US$32.89
+40.1%
11.3%
US$40.00
US$28.00
US$15.36
9
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.